The role of interferon-gamma in the immunotherapy of neuroblastoma

Prog Clin Biol Res. 1991:366:401-7.

Authors

R Handgretinger¹, G Bruchelt, B Daurer, P Lang, M Herter, R Dopfer, B Müller, R A Reisfeld, J Treuner, D Niethammer

Affiliation

¹ Children's University Hospital, Dept. of Haematology/Oncology, Tuebingen, FRG.

PMID: 1906184

No abstract available

MeSH terms

2',5'-Oligoadenylate Synthetase / blood
Antibody-Dependent Cell Cytotoxicity / drug effects
Biomarkers, Tumor / blood
Child
Cytotoxicity, Immunologic / drug effects
Humans
Immunotherapy
Interferon-gamma / pharmacology*
Interferon-gamma / physiology*
Interleukin-2 / pharmacology
Interleukin-2 / therapeutic use*
Killer Cells, Lymphokine-Activated / drug effects
Killer Cells, Lymphokine-Activated / immunology
Killer Cells, Natural / drug effects
Killer Cells, Natural / immunology*
Monocytes / drug effects
Monocytes / immunology*
Neuroblastoma / immunology
Neuroblastoma / therapy*
Recombinant Proteins / pharmacology
Recombinant Proteins / therapeutic use

Substances

Biomarkers, Tumor
Interleukin-2
Recombinant Proteins
Interferon-gamma
2',5'-Oligoadenylate Synthetase